The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction
Open accessAbstract
AIMS: galectin-3 is an emerging biomarker which has been studied in relatively small heart failure (HF) cohorts with predominantly systolic HF. We studied the prognostic value of base-line galectin-3 in a large HF cohort, with preserved and reduced left ventricular ejection fraction (LVEF), and compared this to other biomarkers. METHODS: we studied 592 HF patients who had been hospitalized for HF and were followed for 18 months. The primary end-point was a composite of all-cause mortality and HF hospitalization. RESULTS: a doubling of galectin-3 levels was associated with a hazard ratio (HR) of 1.97 (1.62-2.42) for the primary outcome (P < 0.001). After correction for age, gender, BNP, eGFR, and diabetes the HR was 1.38 (1.07-1.78; P = 0.015). Galectin-3 levels were correlated with higher IL-6 and CRP levels (P < 0.002). Changes of galectin-3 levels after 6 months did not add prognostic information to the base-line value (n = 291); however, combining plasma galectin-3 and BNP levels increased prognostic value over either biomarker alone (ROC analysis, P < 0.05). The predictive value of galectin-3 was stronger in patients with preserved LVEF (n = 114) compared to patients with reduced LVEF (P < 0.001). CONCLUSIONS: galectin-3 is an independent marker for outcome in HF and appears to be particularly useful in HF patients with preserved LVEF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
Dickstein, K., Authors/Task Force Members, Cohen-Solal, A., Filippatos, G., McMurray, J. J. V., Ponikowski, P., Poole-Wilson, P. A., Strömberg, A., van Veldhuisen, D. J., Atar, D., et al. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2008.08.005 · Cited by 3,512
Self-citationYusuf, S., Pfeffer, M. A., Swedberg, K., Granger, C. B., Held, P., McMurray, J. J., Michelson, E. L., Olofsson, B., & Östergren, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14285-7 · Cited by 2,994
Authors/Task Force Members, Dickstein, K., Cohen-Solal, A., Filippatos, G., McMurray, J. J. V., Ponikowski, P., Poole-Wilson, P. A., Stromberg, A., van Veldhuisen, D. J., Atar, D., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn309 · Cited by 2,696
Self-citationPaulus, W. J., Tschöpe, C., Sanderson, J. E., Rusconi, C., Flachskampf, F. A., Rademakers, F. E., Marino, P., Smiseth, O. A., De Keulenaer, G., Leite-Moreira, A. F., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm037 · Cited by 2,679
Sharma, U. C., Pokharel, S., van Brakel, T. J., van Berlo, J. H., Cleutjens, J. P. M., Schroen, B., André, S., Crijns, H. J. G. M., Gabius, H. J., Maessen, J., et al. (2004) · Circulation · doi:10.1161/01.cir.0000147181.65298.4d · Cited by 947
Galectins: structure, function and therapeutic potential
Yang, R.-Y., Rabinovich, G. A., & Liu, F.-T. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399408000719 · Cited by 862
Plasma Cytokine Parameters and Mortality in Patients With Chronic Heart Failure
Rauchhaus, M., Doehner, W., Francis, D. P., Davos, C., Kemp, M., Liebenthal, C., Niebauer, J., Hooper, J., Volk, H.-D., Coats, A. J. S., et al. (2000) · Circulation · doi:10.1161/01.cir.102.25.3060 · Cited by 810
Kondo, M. A., Tajinda, K., Colantuoni, C., Hiyama, H., Seshadri, S., Huang, B., Pou, S., Furukori, K., Hookway, C., Peled, H. J., et al. (2012) · Cited by 655
van Kimmenade, R. R., Januzzi, J. L., Ellinor, P. T., Sharma, U. C., Bakker, J. A., Low, A. F., Martinez, A., Crijns, H. J., MacRae, C. A., Menheere, P. P., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.03.061 · Cited by 567
Galectin-3: A Novel Mediator of Heart Failure Development and Progression
de Boer, R. A., Voors, A. A., Muntendam, P., van Gilst, W. H., & van Veldhuisen, D. J. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfp097 · Cited by 524
Self-citationThe regulation of inflammation by galectin‐3
Henderson, N. C., & Sethi, T. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00794.x · Cited by 522
Jaarsma, T. (2008) · Archives of Internal Medicine · doi:10.1001/archinternmed.2007.83 · Cited by 511
Self-citationvan Veldhuisen, D. J., Cohen-Solal, A., Böhm, M., Anker, S. D., Babalis, D., Roughton, M., Coats, A. J. S., Poole-Wilson, P. A., & Flather, M. D. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.046 · Cited by 468
Self-citationLok, D. J. A., Van Der Meer, P., de la Porte, P. W. B.-A., Lipsic, E., Van Wijngaarden, J., Hillege, H. L., & van Veldhuisen, D. J. (2010) · Clinical Research in Cardiology · doi:10.1007/s00392-010-0125-y · Cited by 465
Self-citationYusuf, S., Pfeffer, Swedberg, K. B., Granger, C. B., Held, P. H., McMurray, J. J. V., Michelson, E. L., Olofsson, B., & Östergren, J. (2003) · Cited by 431
Masson, S., Latini, R., Anand, I. S., Barlera, S., Angelici, L., Vago, T., Tognoni, G., & Cohn, J. N. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.04.069 · Cited by 348
Shah, R. V., Chen-Tournoux, A. A., Picard, M. H., van Kimmenade, R. R. J., & Januzzi, J. L. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq091 · Cited by 326
Galectin-3 in Cardiac Remodeling and Heart Failure
de Boer, R. A., Yu, L., & van Veldhuisen, D. J. (2010) · Current Heart Failure Reports · doi:10.1007/s11897-010-0004-x · Cited by 252
Self-citationJaarsma, T., Wal, M. H. L., Hogenhuis, J., Lesman, I., Luttik, M.-L. A., Veeger, N. J. G. M., & Veldhuisen, D. J. (2004) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2003.09.010 · Cited by 187
Self-citationWedel, H., McMurray, J. J. V., Lindberg, M., Wikstrand, J., Cleland, J. G. F., Cornel, J. H., Dunselman, P., Hjalmarson, Å. C., KJEKSHUS, J. K., Komajda, M., et al. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfn046 · Cited by 171
Lin, Y., Lin, L., Wu, Y., Chien, K., Lee, C., Hsu, R., Chao, C., Wang, S., Hsein, Y.-C., Liao, L.-C., et al. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.09.001 · Cited by 167
Galectin‐3 regulates T‐cell functions
Hsu, D. K., Chen, H., & Liu, F. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00798.x · Cited by 166
Milting, H., Ellinghaus, P., Seewald, M., Cakar, H., Bohms, B., Kassner, A., Körfer, R., Klein, M., Krahn, T., Kruska, L., et al. (2008) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2008.02.018 · Cited by 158
Multi-center determination of galectin-3 assay performance characteristics:
Christenson, R. H., Duh, S., Wu, A. H. B., Smith, A. A., Ábel, G., deFilippi, C. R., Wang, S., Adourian, A. S., Adiletto, C., & Gardiner, P. (2010) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2010.02.001 · Cited by 147
Martos, R., Baugh, J. A., Ledwidge, M. T., O’Loughlin, C., Murphy, N. F., Conlon, C. M., Patle, A. K., Donnelly, S. C., & McDonald, K. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfn036 · Cited by 138
Sharma, U. C., Rhaleb, N., Pokharel, S., Harding, P., Rasoul, S., Peng, H., & Carretero, O. A. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00305.2007 · Cited by 122
The immunological potential of galectin-1 and -3
Dhirapong, A., Lleò, A., Leung, P. S. C., Gershwin, M. E., & Liu, F. (2008) · Autoimmunity Reviews · doi:10.1016/j.autrev.2008.11.009 · Cited by 120
Interferon-γ Induces Chronic Active Myocarditis and Cardiomyopathy in Transgenic Mice
Reifenberg, K., Lehr, H.-A., Torzewski, M., Steige, G., Wiese, E., Küpper, I., Becker, C., Ott, S., Nusser, P., Yamamura, K., et al. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060906 · Cited by 120
Grewal, J., McKelvie, R. S., Persson, H., Tait, P., Carlsson, J., Swedberg, K. B., Östergren, J., & Lonn, E. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.04.048 · Cited by 107
Kirk, V., Bay, M., Parner, J., Krogsgaard, K., Herzog, T., Boesgaard, S., Hassager, C., Nielsen, O. W., Aldershvile, J., & Nielsen, H. (2004) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2004.01.002 · Cited by 104
14-3-3 protein regulates Ask1 signaling and protects against diabetic cardiomyopathy
Thandavarayan, R. A., Watanabe, K., Ma, M., Veeraveedu, P. T., Gurusamy, N., Palaniyandi, S. S., Zhang, S., Muslin, A. J., Kodama, M., & Aizawa, Y. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.02.003 · Cited by 91
Heart Failure With Normal Left Ventricular Ejection Fraction: What is the Evidence?
Kindermann, M., Reil, J., Pieske, B. M., van Veldhuisen, D. J., & Böhm, M. (2008) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2008.12.003 · Cited by 58
Cited by
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.04.025 · Cited by 3,418
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829e8807 · Cited by 3,304
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000509 · Cited by 3,109
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829e8776 · Cited by 2,106
Metadata
- Authors
- de Boer, R. A., Lok, D. J. A., Jaarsma, T., van der Meer, P., Voors, A. A., Hillege, H. L., & van Veldhuisen, D. J.
- Venue
- Annals of Medicine
- Publisher
- Informa UK Limited
- Published
- 2010-12-28
- Volume
- 43
- Issue
- 1
- Pages
- 60-68
- ISSN
- 0785-3890 (ISSN-L)
- 1365-2060
- OpenAlex
- W2015404118
- Cited by
- 592
- References
- 32
- FWCI
- 20.23
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.